Anti-Allergic Ophthalmic Eye Drops Franchise in Ahmedabad

Olopatadine 0.2% Eye Drops Supplier in Mumbai

Allergic Conjunctivitis Eye Drops Distributor in Delhi

Anti-Allergic Ophthalmic PCD Pharma Franchise in Bangalore

Olopatadine Eye Drops Stockist in Hyderabad
Ophthalmic Anti-Allergic Eye Drops Manufacturer & Exporter in Chandigarh

Home/Products /olopatadine-0-2-w-v-eye-drops-eye-drop

Oloplit Plus Eye Drops

Composition : Olopatadine (0.2% w/v) Eye drops

Dosage Form : Eye Drops

Packaging Type : Dropper

Packaging : 5ml

Price : ₹1/-

Oloplit Plus Eye Drops contain Olopatadine (0.2% w/v), a clinically proven antihistamine ophthalmic solution. It provides fast relief from allergic eye symptoms including itching, redness, and watery eyes, making it ideal for patients suffering from seasonal or perennial allergic conjunctivitis.

Olopatadine works by blocking histamine H1 receptors, preventing the allergic cascade and reducing ocular discomfort. Its gentle formulation ensures patient comfort and long-term safety, suitable for repeated use as prescribed by ophthalmologists.

Clinically, Oloplit Plus Eye Drops help maintain eye health and patient compliance, providing once or twice daily dosing convenience while delivering rapid symptom relief.

From a business perspective, Oloplit Plus Eye Drops strengthen the anti-allergic ophthalmic segment, ensuring high prescription demand, repeat sales, and profitable PCD franchise opportunities for distributors and stockists across India.

Read More

About the Product

Oloplit Plus Eye Drops contain Olopatadine (0.2% w/v), a clinically proven antihistamine ophthalmic solution. It provides fast relief from allergic eye symptoms including itching, redness, and watery eyes, making it ideal for patients suffering from seasonal or perennial allergic conjunctivitis.

Olopatadine works by blocking histamine H1 receptors, preventing the allergic cascade and reducing ocular discomfort. Its gentle formulation ensures patient comfort and long-term safety, suitable for repeated use as prescribed by ophthalmologists.

Clinically, Oloplit Plus Eye Drops help maintain eye health and patient compliance, providing once or twice daily dosing convenience while delivering rapid symptom relief.

From a business perspective, Oloplit Plus Eye Drops strengthen the anti-allergic ophthalmic segment, ensuring high prescription demand, repeat sales, and profitable PCD franchise opportunities for distributors and stockists across India.

Common side effects may include mild burning or stinging, temporary blurred vision, eye irritation, or dryness. Rarely, hypersensitivity reactions may occur.

Oloplit Plus Eye Drops are indicated for the treatment and prevention of allergic conjunctivitis, including seasonal and perennial ocular allergies. They help control symptoms such as itching, redness, and watery eyes caused by allergens.

Use Oloplit Plus Eye Drops strictly as prescribed by an ophthalmologist. Avoid touching the dropper tip to the eye or any surface to prevent contamination. Discontinue use and consult a doctor if severe irritation, persistent redness, or allergic reactions occur.

Store in a cool, dry place below 25°C. Protect from direct sunlight, keep the bottle tightly closed, and out of reach of children. Do not use beyond the expiry date.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation